Prelude Therapeutics Incorporated

Gisela Saborit Villarroya

Michael Hawkins

Juan Luengo

Hong Lin

Philip Michael Pitis

Rupa S Shetty

Rupa Shetty

The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

The disclosure is directed to methods of treatment using compounds of Formula (I).

The disclosure is directed to compounds of Formula I  Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.

Growing community of inventors

Barcelona, Spain

Gisela Saborit Villarroya